Victoria's Secret Board Battle: Turnaround Success vs. Activist Demands
- 164% Total Shareholder Returns: Since CEO Hillary Super's appointment in late 2024, Victoria's Secret has delivered a 164% surge in shareholder value, outperforming key market indices by 124% and peers by 172%.
- 13% Stake: BBRC International Pte Limited, the company's second-largest stockholder, holds a 13% stake and alleges 92 percentage points of underperformance compared to the retail index.
- 20-Year Tenure: BBRC targets Board Chair Donna James, criticizing her over two-decade tenure as incompatible with good corporate governance.
Experts would likely conclude that while Victoria's Secret's recent turnaround under new leadership shows promising short-term results, the activist investor's long-term underperformance claims highlight deeper governance and strategic challenges that shareholders must weigh carefully.
Victoria's Secret Boardroom Battle Heats Up Over Turnaround Strategy
REYNOLDSBURG, Ohio – May 05, 2026 – A high-stakes corporate drama is unfolding at Victoria’s Secret & Co. as its Board of Directors has forcefully pushed back against a proxy contest launched by activist investor BBRC International Pte Limited. In a statement released today, the lingerie giant's board defended its leadership and strategy, highlighting a dramatic surge in shareholder value while painting the activist's campaign as a self-serving effort by its chairman, Brett Blundy, after he was denied a seat on the board.
The conflict sets the stage for a critical showdown at the company’s upcoming 2026 Annual Meeting of Shareholders. At its core is a fundamental disagreement over the company's performance and future direction. The board is championing its "Path to Potential" strategy, which it credits for a remarkable turnaround, while BBRC, the company's second-largest stockholder with a stake of approximately 13%, alleges deep-seated mismanagement and demands change by urging shareholders to withhold votes for two incumbent directors, including Board Chair Donna James.
A Tale of Two Timelines
The battle of narratives hinges on conflicting interpretations of the company's financial performance. Victoria's Secret's board is focusing on the period since the late 2024 announcement of CEO Hillary Super's appointment. By their measure, the company has delivered an astounding 164% in total shareholder returns, a figure that trounces key market indices. The company claims this performance outpaces the S&P 500 Consumer Discretionary Distribution & Retail Index by 124% and a group of its peers by 172%.
This glowing report of recent success is directly contradicted by BBRC's assessment. The investment firm, which began building its position around 2022, argues that over the course of its investment, Victoria's Secret shares have massively underperformed the same retail index by approximately 92 percentage points. This stark discrepancy highlights the central question for shareholders: should they focus on the recent, explosive growth under new leadership, or on the longer-term value erosion that BBRC claims points to systemic issues? The market has responded favorably to the recent changes, with the stock surging on Super's appointment and after multiple earnings beats in 2025, lending credence to the board's turnaround story.
The Activist's Case and the Board's Rejection
BBRC's campaign targets what it calls a "stale perspective" on the board, specifically aiming to unseat Chair Donna James, whose long tenure of over two decades they argue is "incompatible with good corporate governance." The activist also criticizes the board's oversight on capital allocation and mergers, and suggests non-executive directors have minimal stock ownership, implying a lack of alignment with shareholder interests.
However, Victoria's Secret's board has countered that BBRC’s campaign is not about governance, but about its chairman Brett Blundy’s personal ambition. According to the company, Blundy’s primary focus over years of engagement has been to secure a board seat for himself. The board stated it conducted a "thorough and independent evaluation" of Blundy's candidacy twice, most recently in November 2025, and rejected him after concluding his appointment would introduce "serious reputational, legal, conflict of interest and governance risks."
While the board's statement was general, the potential risks are specific. BBRC is reportedly preparing to launch a new global lingerie chain called Leays, creating a direct and significant conflict of interest for Blundy on the board of a major competitor. Furthermore, Blundy's fast-fashion jewelry retailer, Lovisa, is facing a lawsuit over alleged staff underpayment. Adding another layer of complexity, BBRC itself was found to have accumulated its stake in Victoria's Secret for nearly three years without making the legally required antitrust filings under the Hart-Scott-Rodino Act, a lapse it later corrected. The board claims it offered a compromise—including adding a mutually agreed-upon director and giving Blundy input on capital allocation—but that he "refused to meaningfully engage on a resolution that did not include his own appointment."
'Path to Potential' Under Scrutiny
Central to the board's defense is the "Path to Potential" strategy, a comprehensive roadmap introduced by CEO Hillary Super in March 2025. This plan is built on supercharging its core bra business, recommitting to the PINK brand, growing its beauty and lifestyle segments, and evolving its brand image to be more inclusive and relevant. The company has moved to shed its long-criticized "fantasy" image in favor of a broader appeal, a major strategic pivot for the iconic brand.
To execute this vision, Super has assembled a new leadership team, including new presidents for Victoria's Secret, PINK, and Beauty. The company's recent financial results suggest the strategy is gaining traction. It posted impressive results for the second, third, and fourth quarters of fiscal 2025, consistently beating revenue and earnings forecasts and demonstrating growth across its brands. The board argues that BBRC's proxy contest is a "distracting campaign" that threatens to derail this carefully orchestrated momentum at a crucial juncture.
What's at Stake for Shareholders
As the annual meeting approaches, shareholders are left to weigh the competing claims. On one side is a board and a new CEO delivering tangible, impressive short-term results and executing a clear strategic shift. On the other is a major shareholder who has endured significant paper losses and is demanding a governance overhaul, arguing the recent upswing does not erase years of underperformance and entrenched leadership.
Adding another dynamic to the situation is the impending expiration of the company's shareholder rights plan, or "poison pill," on May 18, 2026. The defensive measure was adopted in response to BBRC's share accumulation and a prior acquisition proposal. The board has stated it does not intend to extend the plan, a move that removes a key barrier to a potential takeover and could heighten the stakes of the current proxy fight. Ultimately, the vote to support or withhold votes from directors Donna James and Mariam Naficy will serve as a referendum on whether shareholders believe the company is firmly on the path to potential, or if a more disruptive change is needed to secure its future.
📝 This article is still being updated
Are you a relevant expert who could contribute your opinion or insights to this article? We'd love to hear from you. We will give you full credit for your contribution.
Contribute Your Expertise →